C

Citius Oncology
CTOR

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$47.94M
EV
$51.74M
Shares Outstanding
71.55M
Beta
-0.19

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$3.00
P/E 2025E
-
P/Revenue 2025E
1.67x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Citius Oncology, Inc.

gainify

C

Citius Oncology, Inc.

CTOR

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered i...

Sector

Industry

CEO

Mazur, Leonard

Employees

IPO Date

Headquarters

420 Lexington Avenue, Suite 2446, New York, New York, 10170, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved